	A computational-based search of natural product derived multi-target ligands for the management of Alzheimer's and Parkinson's disease using structure-based pharmacophore modelling, virtual screening, MD docking, free energy analysis, ADMET profiling and DFT studies. SAR QSAR Environ Res Chhabra N, Matore BW, Murmu A, Kumar A, Gawande P, Singh J, Roy PP. PMID: 41255260 [PubMed - indexed for MEDLINE]
	"YiJinJing, Wohu Pushi" Posture-Voice Therapy for Dysarthria in Parkinson's Disease Patients Following Subthalamic Nucleus Deep Brain Stimulation: A Randomized Controlled Trial. CNS Neurosci Ther Yang M, Sun X, Yan J, Zeng Z, Tan Y, Yan S, Wang Y, Wang L, Niu CM, Li D. PMID: 41254931 [PubMed - indexed for MEDLINE]
	Construction of a mild cognitive impairment prediction model for Parkinson's disease patients on the basis of multimodal data. NPJ Parkinsons Dis Liang C, Chen Y, Zhu Y, Zhu Y, Chen J, Liu C, Wang F, Yang X. PMID: 41253859 [PubMed]
	The genetics of autosomal recessive early-onset Parkinson's disease. Curr Opin Neurobiol Cogan G, Lesage S, Brice A. PMID: 41253044 [PubMed - as supplied by publisher]
	Reactive astrocyte-related pathogenic genes in Parkinson's disease: A multi-omics Mendelian randomization study. J Parkinsons Dis Wang H, Hu J, Mo B, Li J, Cai H, Li Q. PMID: 41252303 [PubMed - as supplied by publisher]
	Foods and Dietary Intakes and the Risk of Parkinson's Disease: A Systematic Review and Dose-Response Meta-analysis of Prospective Cohort Studies. Nutr Rev Akhlaghi M, Foshati S, Hashemi Moghaddam F, Sasani MR, Kazemi A. PMID: 41252180 [PubMed - as supplied by publisher]
	Do microplastics play a role in the pathogenesis of neurodegenerative diseases? Shared pathophysiological pathways for Alzheimer's and Parkinson's disease. Mol Cell Biochem Siu ACW, Paudel KR, Singh G, Gupta G, Singh SK, Chellappan DK, De Rubis G, Pathak S, Gregory George Oliver B, Dua K, Dhanasekaran M. PMID: 41252097 [PubMed - as supplied by publisher]
	Resting-state EEG changes associated with cognitive decline in Parkinson's disease: a systematic review. J Neural Transm (Vienna) Spoa M, Monti S, Bjeki, Guerra A, Fiorenzato E, Cauzzo S, Bertoldo A, Antonini A. PMID: 41251764 [PubMed - as supplied by publisher]
	Impact of device-aided therapies on quality of life in patients with Parkinson's disease. A comparative multicenter observational study. J Neural Transm (Vienna) Santos-García D, Solleiro Á, González-Ortega G, Mir P, López-Ariztegui N, Legarda I, Rojas-Pérez ME, Peral-Quirós A, Cabo I, García-Ramos R, Sánchez-Alonso P, Hernández-Vara J, Blázquez-Estrada M, Sánchez-Ferro Á, DATs-PD GETM Spanish Registry Group. PMID: 41251763 [PubMed - as supplied by publisher]
	Genome-Wide Meta-Analysis of Parkinson's Disease Associated Genetic Loci and Validation of Therapeutic Targets. Brain Behav Yang S, Wu Q, Yang X. PMID: 41251092 [PubMed - indexed for MEDLINE]
	Posturographic Markers for Early-Stage Parkinson's Disease in Elderly Patients Presenting with Dizziness: A Case Series in an ENT Clinic. Tokai J Exp Clin Med Yamamoto A, Goto F, Iijima H, Kaneda S, Okami K, Wasano K. PMID: 41250564 [PubMed - indexed for MEDLINE]
	Multiple Case Studies on the Effects of Aroma Massage for Pain Relief and Quality of Life in Parkinson's Disease Patients. Tokai J Exp Clin Med Aoyama I, Nogami T, Nagata E. PMID: 41250562 [PubMed - indexed for MEDLINE]
	'Breaking the stigma': a qualitative study on how public perceptions affect individuals with Parkinson's disease - a nurse specialist perspective. BMC Geriatr Crooks S, Mitchell G, Wynne L, Carter G. PMID: 41249959 [PubMed - indexed for MEDLINE]
	Drp1 in Parkinson's disease: Mechanisms of disease pathology and the promise of targeted therapeutic strategies. Life Sci Liu S, Huang Z, Yin Z, Chen L, Ye L, Zhang D, Bai X. PMID: 41248826 [PubMed - as supplied by publisher]
	Protein mechanism and therapeutic design in Parkinson's disease: A structural biology perspective. Curr Opin Neurobiol Simons DM, Trempe JF. PMID: 41248610 [PubMed - as supplied by publisher]
	CSF Î±-Synuclein Seed Amplification Assays and Alzheimer Disease Biomarkers in Dementia With Lewy Bodies: Presentation and Progression. Neurology Coughlin DG, Jain L, Khrestian M, Bozoki AC, Galvin JE, Irwin DJ, Lippa CF, Litvan I, Pillai JA, Tousi B, Lopez OL, Berman S, Tsuang DW, Zabetian CP, Fleisher JE, Taylor AS, Leverenz JB, Bekris LM, Galasko D, Dementia With Lewy Bodies Consortium. PMID: 41248454 [PubMed - indexed for MEDLINE]
	Nocturnal Hypokinesia and Early Morning OFF in Parkinson's Disease: State-of-the-Art and Systematic Review of Treatment Availability. Curr Neurol Neurosci Rep Sringean J, Carandang RAM, Zhunusova E, Bhidayasiri R. PMID: 41247590 [PubMed - indexed for MEDLINE]
	Estimating the burden of dementia and parkinsonism through a novel identification algorithm based on healthcare administrative data. Front Public Health Sabbatinelli J, Biscetti L, Lilla M, Giuliani A, Balducci F, Ramini D, Rupelli G, Pompili M, Pelliccioni G, Recchioni R, Capalbo M, Vanacore N, Olivieri F, Spazzafumo L. PMID: 41246054 [PubMed - indexed for MEDLINE]
	Exploring gut microbiota alterations in Parkinson's disease: insights from a 16S amplicon sequencing Eastern European pilot study. Front Neurosci Ilie OD, V, Am, Nita IB, Dobrin PR, Doroftei M, Ivanov IC, Savuta G, Kirov B, Doroftei B. PMID: 41245833 [PubMed]
	Parkinson's disease in the spinal cord: An exploratory study to establish T2*w, MTR and diffusion-weighted imaging metric values. Imaging Neurosci (Camb) St-Onge S, Coustaury C, Landelle C, Dahlberg LS, Lungu O, Doyon J, De Leener B. PMID: 41245371 [PubMed]

Articles 1 - 20 / 55343

Page 1 of 2768



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy